StockData
agilon health, inc. logo

agilon health, inc. (AGL) stock

AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$90.53−24.67 (-21.41%)

Close on Nov 18, 2026Market cap $1.52BP/E –Yield –

agilon health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

agilon health's operating income for the twelve months ending Jun 30, 2026 was -$309.33M. For fiscal 2025 it was -$463.24M. The highest annual figure on record is -$56.67M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$463.24M–
FY2024Dec 31, 2024-$292.13M–
FY2023Dec 31, 2023-$232.13M–
FY2022Dec 31, 2022-$105.38M–
FY2021Dec 31, 2021-$372.24M–
FY2020Dec 31, 2020-$56.67M–
FY2019Dec 31, 2019-$106.57M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.77M–
Q1 FY2026Mar 31, 2026$4.00M–
Q4 FY2025Dec 31, 2025-$193.83M–
Q3 FY2025Sep 30, 2025-$131.27M–
Q2 FY2025Jun 30, 2025-$116.03M–
Q1 FY2025Mar 31, 2025-$22.11M–
Q4 FY2024Dec 31, 2024-$108.10M–
Q3 FY2024Sep 30, 2024-$133.51M–
Q2 FY2024Jun 30, 2024-$43.34M–
Q1 FY2024Mar 31, 2024-$7.18M-1821.3%
Q4 FY2023Dec 31, 2023-$164.30M–
Q3 FY2023Sep 30, 2023-$39.29M–
Q2 FY2023Jun 30, 2023-$28.96M–
Q1 FY2023Mar 31, 2023$417.00K–
Q4 FY2022Dec 31, 2022-$54.07M–
Q3 FY2022Sep 30, 2022-$29.52M–
Q2 FY2022Jun 30, 2022-$21.05M–
Q1 FY2022Mar 31, 2022-$743.00K–
Q4 FY2021Dec 31, 2021-$26.16M–
Q3 FY2021Sep 30, 2021-$35.60M–
Q2 FY2021Jun 30, 2021-$298.36M–
Q1 FY2021Mar 31, 2021-$12.12M–
Q4 FY2020Dec 31, 2020-$39.74M–
Q3 FY2020Sep 30, 2020-$9.84M–
Q2 FY2020Jun 30, 2020-$1.25M–
Q1 FY2020Mar 31, 2020-$5.83M–

More agilon health figures

See a number that looks wrong?